SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-020760
Filing Date
2017-04-17
Accepted
2017-04-17 17:30:19
Documents
10
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v464063_10k.htm 10-K 636950
2 EXHIBIT 4.10 v464063_ex4-10.htm EX-4.10 77872
3 EXHIBIT 4.11 v464063_ex4-11.htm EX-4.11 79581
4 EXHIBIT 4.12 v464063_ex4-12.htm EX-4.12 36690
5 EXHIBIT 10.18.3 v464063_ex10-18x3.htm EX-10.18X3 44225
6 EXHIBIT 10.21 v464063_ex10-21.htm EX-10.21 152502
7 EXHIBIT 23.1 v464063_ex23-1.htm EX-23.1 2598
8 EXHIBIT 31.1 v464063_ex31-1.htm EX-31.1 9695
9 EXHIBIT 31.2 v464063_ex31-2.htm EX-31.2 9936
10 EXHIBIT 32.1 v464063_ex32-1.htm EX-32.1 4821
  Complete submission text file 0001144204-17-020760.txt   1055947
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32715 | Film No.: 17765417
SIC: 2835 In Vitro & In Vivo Diagnostic Substances